Cargando…

Post-chemotherapy serum anti-Müllerian hormone level predicts ovarian function recovery

In the era of precision medicine, the prediction of ovarian function recovery from chemotherapy-induced amenorrhoea using feasible biological markers may be helpful to optimise the treatment strategy for young patients with hormone receptor-positive breast cancer. The purpose of this study was to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun-Ah, Choi, Jihye, Park, Chan Sub, Seong, Min-Ki, Hong, Sung-Eun, Kim, Jae-Sung, Park, In-Chul, Lee, Jin Kyung, Noh, Woo Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144937/ https://www.ncbi.nlm.nih.gov/pubmed/30300533 http://dx.doi.org/10.1530/EC-18-0180

Ejemplares similares

Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?
por: Lee, Juhyeon, et al.
Publicado: (2023)

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer
por: Park, Chan Sub, et al.
Publicado: (2019)

Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
por: Choi, Jihye, et al.
Publicado: (2019)

Clinical application of anti-Müllerian hormone as a predictor of controlled ovarian hyperstimulation outcome
por: Lee, Jae Eun, et al.
Publicado: (2012)

Preoperative Serum Anti-Mullerian Hormone Level in Women with Ovarian Endometrioma and Mature Cystic Teratoma
por: Kim, Ju Yeong, et al.
Publicado: (2013)

Anti-Mullerian Hormone Changes Following Laparoscopic Ovarian Cystectomy: A Prospective Comparative Study
por: Cho, Hye-yon, et al.
Publicado: (2021)

Predicting Radiation Resistance in Breast Cancer with Expression Status of Phosphorylated S6K1
por: Choi, Jihye, et al.
Publicado: (2020)

Serum anti-Müllerian hormone levels as a predictor of the ovarian response and IVF outcomes
por: Choi, Min Hye, et al.
Publicado: (2011)

The Significance of p-AKT1 as a Prognostic Marker and Therapeutic Target in Patients With Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor-2-Positive Early Breast Cancer
por: Kim, Ji Yea, et al.
Publicado: (2022)

Surgical impact on serum anti-Müllerian hormone in women with benign ovarian cyst: A prospective study
por: Jang, Won Kyu, et al.
Publicado: (2014)

Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
por: Cabiscuelas, Charmaine A., et al.
Publicado: (2021)

Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosis
por: Yoo, Ji Hee, et al.
Publicado: (2011)

Serum Anti-Müllerian Hormone Levels in Patients with Epithelial Ovarian Cancer
por: Walentowicz, Pawel, et al.
Publicado: (2013)

Ovarian dysgerminoma with Müllerian anomaly: a case report
por: Kim, Ha Na, et al.
Publicado: (2020)

The meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian response
por: Park, Hyun Jong, et al.
Publicado: (2016)

Correlation of oocyte number with serum anti-Müllerian hormone levels measured by either Access or Elecsys in fresh in vitro fertilization cycles
por: Jeong, Hye Gyeong, et al.
Publicado: (2022)

Serum anti-Müllerian hormone recovery after ovarian cystectomy for endometriosis: A retrospective study among Korean women
por: Lee, Juhun, et al.
Publicado: (2022)

Serum Anti-Müllerian Hormone Levels before Surgery in Patients with Ovarian Endometriomas Compared to Other Benign Ovarian Cysts
por: Jeon, Ji Hyun, et al.
Publicado: (2015)

Serum Anti-Müllerian Hormone and Inhibin B Levels at Ovulation Triggering Day Can Predict the Number of Immature Oocytes Retrieved in In Vitro Fertilization Cycles
por: Jee, Byung Chul, et al.
Publicado: (2008)

Association between serum anti-Müllerian hormone level and ovarian response to mild stimulation in normoovulatory women and anovulatory women with polycystic ovary syndrome
por: Kim, Ju Yeong, et al.
Publicado: (2013)

Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome
por: Parco, Sergio, et al.
Publicado: (2011)

Serum anti-Mullerian hormone predicts ovarian response in (Macaca fascicularis) monkeys
por: Long, Hui, et al.
Publicado: (2018)

Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value
por: Song, Do Kyeong, et al.
Publicado: (2017)

Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: Cai, Yan, et al.
Publicado: (2022)

The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia
por: Zamani, Mehrangiz, et al.
Publicado: (2023)

Correlation of Serum Anti-Mullerian Hormone (AMH) Level on Ovarian Volume in Women with Endometrioma
por: Suardi, Dodi, et al.
Publicado: (2021)

Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer
por: Kim, Hyun-Ah, et al.
Publicado: (2015)

Correlation between the Serum Luteinizing Hormone to Folliclestimulating Hormone Ratio and the Anti-Müllerian Hormone Levels in Normo-ovulatory Women
por: Lee, Jong Eun, et al.
Publicado: (2015)

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy
por: Kim, Hyung Jin, et al.
Publicado: (2023)

Serum anti-müllerian hormone levels in evaluation of chemotherapy effect on ovarian reserve in women with breast cancer: A follow-up study
por: Al-Rawi, Safana A., et al.
Publicado: (2018)

Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function
por: Moolhuijsen, Loes M E, et al.
Publicado: (2020)

Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor
por: Woo, Sang Hyeok, et al.
Publicado: (2016)

Impact of laparoscopic ovarian drilling on serum anti-mullerian hormone levels in patients with anovulatory Polycystic Ovarian syndrome
por: Paramu, Sobhana
Publicado: (2016)

Retracted: Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency
por: International, BioMed Research
Publicado: (2023)

Association between cadmium and anti-Mullerian hormone in premenopausal women at particular ages
por: Lee, Yu min, et al.
Publicado: (2018)

Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment
por: Seok, Hyun Ha, et al.
Publicado: (2016)

Evaluation of the Ovarian Reserve in Adolescents with Hashimoto’s Thyroiditis Using Serum Anti-Müllerian Hormone Levels
por: Özalp Akın, Ezgi, et al.
Publicado: (2018)

Age specific serum anti-Müllerian hormone levels in 1,298 Korean women with regular menstruation
por: Yoo, Ji Hee, et al.
Publicado: (2011)

Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer()
por: Anderson, Richard A., et al.
Publicado: (2013)

Can high serum anti-Müllerian hormone levels predict the phenotypes of polycystic ovary syndrome (PCOS) and metabolic disturbances in PCOS patients?
por: Hwang, Yu Im, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j6ikja8quch2eikm1u46foe6fk